Optimal Dosage of Upadacitinib in Crohn's Disease Patients: Experience from Real World Setting

被引：0
|
作者：
Juillerat, Pascal [1 ,2 ,3 ]
Martinho-Grueber, Maude [1 ,2 ]
Ruetsch, Roseline [2 ]
Moubayed, Hayssam [1 ]
Vulliemoz, Marianne [1 ]
Michetti, Pierre [1 ,2 ,4 ]
机构：
[1] Crohn & Colitis Ctr, Gastroenterol Beaulieu, Lausanne, Switzerland
[2] Gastroenterol Ctr, Bulle, Switzerland
[3] Bern Univ Hosp, Clin Visceral Surg & Med, Bern, Switzerland
[4] CHU Vaudois, Gastroenterol & Hepatol, Lausanne, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2023年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
G4
引用
收藏
页码：26S / 26S
页数：1
相关论文
共 50 条
  • [1] Upadacitinib in Crohn's Disease Patients: for what type of patients in real world setting ?
    Juillerat, P.
    Martinho-Grueber, M.
    Ruetsch, R.
    Moubayed, H.
    Vulliemoz, M.
    Michetti, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2059 - I2059
  • [2] Upadacitinib in Crohn's Disease Patients: for what type of patients in real world setting?
    Juillerat, Pascal
    Martinho-Grueber, Maude
    Ruetsch, Roseline
    Moubayed, Hayssam
    Vulliemoz, Marianne
    Michetti, Pierre
    SWISS MEDICAL WEEKLY, 2023, 153 : 26S - 26S
  • [3] Upadacitinib in Crohn's disease: real-world experience
    Mir, Adil S.
    MINERVA GASTROENTEROLOGY, 2024, 70 (04): : 442 - 445
  • [4] Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease
    Chugh, Rishika
    Braga-Neto, Manuel B.
    Fredrick, Thomas W.
    Ramos, Guilherme P.
    Terdiman, Jonathan
    El-Nachef, Najwa
    Loftus, Edward, V
    Mahadevan, Uma
    Kane, Sunanda, V
    JOURNAL OF CROHNS & COLITIS, 2022, : 504 - 512
  • [5] Upadacitinib in Crohn's disease: Real world experience from an early access program in Greece
    Papathanasiou, E.
    Leonidakis, G.
    Michalopoulos, G.
    Manolakopoulos, S.
    Siakavellas, S.
    Theodoropoulou, A.
    Tasovasili, A.
    Giouleme, O.
    Tzouvala, M.
    Tsironi, E.
    Viazis, N.
    Michopoulos, S.
    Zampeli, E.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1350 - I1351
  • [6] UPADACITINIB IS EFFECTIVE AND SAFE FOR CROHN'S DISEASE: PROSPECTIVE REAL-WORLD EXPERIENCE
    Friedberg, Scott
    Choi, David
    Hunold, Thomas
    Choi, Natalie K.
    Garcia, Nicole M.
    Picker, Emma A.
    Cohen, Nathaniel A.
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Sakuraba, Atsushi
    Cleveland, Noa Krugliak
    Rubin, David T.
    GASTROENTEROLOGY, 2023, 164 (06) : S1126 - S1126
  • [7] Upadacitinib is effective and safe for Crohn's Disease: prospective real-world experience
    Friedberg, S.
    Choi, D.
    Hunold, T.
    Choi, N. K.
    Garcia, N. M.
    Picker, E. A.
    Cohen, N. A.
    Cohen, R. D.
    Dalal, S. R.
    Pekow, J.
    Sakuraba, A.
    Cleveland, N. K.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 931 - 933
  • [8] Efficacy and safety of upadacitinib during induction in Crohn's disease: Real-world experience
    Jairath, R.
    Zoughlami, A.
    Pilote, N.
    Afif, W.
    Bitton, A.
    Wild, G.
    Narula, N.
    Lakatos, P. L.
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1337 - I1337
  • [9] REAL-WORLD OUTCOMES FOR UPADACITINIB IN CROHN'S DISEASE PATIENTS AT A SINGLE CENTER
    Chugh, Rishika
    Terdiman, Jonathan P.
    El-Nachef, Najwa
    Wolf, Libby
    Mahadevan, Uma
    GASTROENTEROLOGY, 2022, 162 (07) : S990 - S990
  • [10] Real World Experience With Off-Label Upadacitinib in Crohn's Disease at a Tertiary Care Center
    Braga Neto, Manuel Bonfim
    Schoenoff, Shayla
    Becker, Michelle
    Loftus, Edward V.
    Kane, Sunanda V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S367 - S368
12345